nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—CYP2B6—Thiotepa—urinary bladder cancer	0.0708	0.115	CbGbCtD
Quinidine—ABCB1—Mitomycin—urinary bladder cancer	0.0479	0.0777	CbGbCtD
Quinidine—ABCB11—Doxorubicin—urinary bladder cancer	0.0392	0.0635	CbGbCtD
Quinidine—SLC22A2—Cisplatin—urinary bladder cancer	0.0376	0.061	CbGbCtD
Quinidine—ABCC2—Carboplatin—urinary bladder cancer	0.036	0.0583	CbGbCtD
Quinidine—ABCC2—Cisplatin—urinary bladder cancer	0.0307	0.0498	CbGbCtD
Quinidine—ABCC2—Etoposide—urinary bladder cancer	0.0302	0.049	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—urinary bladder cancer	0.0241	0.039	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—urinary bladder cancer	0.0227	0.0368	CbGbCtD
Quinidine—CYP3A4—Thiotepa—urinary bladder cancer	0.0218	0.0353	CbGbCtD
Quinidine—SLC22A8—Methotrexate—urinary bladder cancer	0.021	0.034	CbGbCtD
Quinidine—ABCC2—Doxorubicin—urinary bladder cancer	0.0206	0.0334	CbGbCtD
Quinidine—ABCC2—Methotrexate—urinary bladder cancer	0.02	0.0323	CbGbCtD
Quinidine—CYP2B6—Cisplatin—urinary bladder cancer	0.0195	0.0317	CbGbCtD
Quinidine—CYP2E1—Etoposide—urinary bladder cancer	0.0195	0.0316	CbGbCtD
Quinidine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0174	0.0282	CbGbCtD
Quinidine—CYP2C8—Etoposide—urinary bladder cancer	0.0145	0.0236	CbGbCtD
Quinidine—ABCB1—Gemcitabine—urinary bladder cancer	0.0138	0.0224	CbGbCtD
Quinidine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0135	0.0219	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0131	0.0212	CbGbCtD
Quinidine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0122	0.0197	CbGbCtD
Quinidine—CYP1A2—Etoposide—urinary bladder cancer	0.0113	0.0182	CbGbCtD
Quinidine—CYP2C9—Cisplatin—urinary bladder cancer	0.0103	0.0167	CbGbCtD
Quinidine—ABCB1—Cisplatin—urinary bladder cancer	0.01	0.0162	CbGbCtD
Quinidine—ABCB1—Etoposide—urinary bladder cancer	0.00984	0.016	CbGbCtD
Quinidine—ABCB1—Doxorubicin—urinary bladder cancer	0.00671	0.0109	CbGbCtD
Quinidine—ABCB1—Methotrexate—urinary bladder cancer	0.0065	0.0105	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00633	0.0103	CbGbCtD
Quinidine—CYP3A4—Etoposide—urinary bladder cancer	0.0059	0.00956	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00402	0.00652	CbGbCtD
Quinidine—SLC22A8—urine—urinary bladder cancer	0.00372	0.0447	CbGeAlD
Quinidine—KCNK6—female reproductive system—urinary bladder cancer	0.00359	0.0431	CbGeAlD
Quinidine—KCNK1—prostate gland—urinary bladder cancer	0.00291	0.035	CbGeAlD
Quinidine—CYP1A2—urine—urinary bladder cancer	0.00255	0.0306	CbGeAlD
Quinidine—KCNK1—seminal vesicle—urinary bladder cancer	0.00246	0.0296	CbGeAlD
Quinidine—CYP2C9—urine—urinary bladder cancer	0.00242	0.0291	CbGeAlD
Quinidine—CYP2E1—urine—urinary bladder cancer	0.00229	0.0276	CbGeAlD
Quinidine—KCNK1—renal system—urinary bladder cancer	0.00198	0.0238	CbGeAlD
Quinidine—KCNK1—urethra—urinary bladder cancer	0.00195	0.0234	CbGeAlD
Quinidine—CYP3A4—urine—urinary bladder cancer	0.00185	0.0222	CbGeAlD
Quinidine—CYP2D6—urine—urinary bladder cancer	0.00182	0.0218	CbGeAlD
Quinidine—SCN3A—prostate gland—urinary bladder cancer	0.00174	0.021	CbGeAlD
Quinidine—ORM1—prostate gland—urinary bladder cancer	0.00159	0.0191	CbGeAlD
Quinidine—SLC22A4—prostate gland—urinary bladder cancer	0.00153	0.0183	CbGeAlD
Quinidine—CHRM2—prostate gland—urinary bladder cancer	0.00148	0.0178	CbGeAlD
Quinidine—KCNK1—vagina—urinary bladder cancer	0.00144	0.0173	CbGeAlD
Quinidine—SLC22A2—renal system—urinary bladder cancer	0.0014	0.0169	CbGeAlD
Quinidine—SLC22A8—prostate gland—urinary bladder cancer	0.00134	0.0161	CbGeAlD
Quinidine—ABCC2—prostate gland—urinary bladder cancer	0.0013	0.0157	CbGeAlD
Quinidine—SLC22A4—seminal vesicle—urinary bladder cancer	0.00129	0.0155	CbGeAlD
Quinidine—SCN3A—renal system—urinary bladder cancer	0.00119	0.0143	CbGeAlD
Quinidine—SLCO1B1—renal system—urinary bladder cancer	0.00117	0.0141	CbGeAlD
Quinidine—KCNH2—prostate gland—urinary bladder cancer	0.00107	0.0128	CbGeAlD
Quinidine—SLC22A4—renal system—urinary bladder cancer	0.00104	0.0125	CbGeAlD
Quinidine—SLC22A5—prostate gland—urinary bladder cancer	0.00101	0.0121	CbGeAlD
Quinidine—SLC22A1—renal system—urinary bladder cancer	0.000991	0.0119	CbGeAlD
Quinidine—SCN2A—vagina—urinary bladder cancer	0.000979	0.0118	CbGeAlD
Quinidine—SLCO1A2—renal system—urinary bladder cancer	0.000954	0.0115	CbGeAlD
Quinidine—SCN3A—female reproductive system—urinary bladder cancer	0.000952	0.0114	CbGeAlD
Quinidine—SLCO1B1—female reproductive system—urinary bladder cancer	0.000939	0.0113	CbGeAlD
Quinidine—KCNK1—lymph node—urinary bladder cancer	0.00093	0.0112	CbGeAlD
Quinidine—SLC22A8—renal system—urinary bladder cancer	0.000911	0.0109	CbGeAlD
Quinidine—KCNH2—seminal vesicle—urinary bladder cancer	0.000904	0.0109	CbGeAlD
Quinidine—ABCC2—renal system—urinary bladder cancer	0.000889	0.0107	CbGeAlD
Quinidine—ORM1—female reproductive system—urinary bladder cancer	0.000866	0.0104	CbGeAlD
Quinidine—SCN3A—vagina—urinary bladder cancer	0.000861	0.0103	CbGeAlD
Quinidine—SCN5A—vagina—urinary bladder cancer	0.000858	0.0103	CbGeAlD
Quinidine—SLC22A5—seminal vesicle—urinary bladder cancer	0.000855	0.0103	CbGeAlD
Quinidine—SLC22A4—female reproductive system—urinary bladder cancer	0.000833	0.01	CbGeAlD
Quinidine—CYP2E1—prostate gland—urinary bladder cancer	0.000823	0.00989	CbGeAlD
Quinidine—SLC22A4—vagina—urinary bladder cancer	0.000754	0.00906	CbGeAlD
Quinidine—KCNH2—renal system—urinary bladder cancer	0.000729	0.00876	CbGeAlD
Quinidine—SLC22A1—vagina—urinary bladder cancer	0.000718	0.00862	CbGeAlD
Quinidine—KCNH2—urethra—urinary bladder cancer	0.000716	0.0086	CbGeAlD
Quinidine—ABCC2—female reproductive system—urinary bladder cancer	0.000712	0.00855	CbGeAlD
Quinidine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000696	0.00837	CbGeAlD
Quinidine—SLC22A5—renal system—urinary bladder cancer	0.000689	0.00827	CbGeAlD
Quinidine—SLC22A5—urethra—urinary bladder cancer	0.000676	0.00813	CbGeAlD
Quinidine—CYP2C8—renal system—urinary bladder cancer	0.000667	0.00801	CbGeAlD
Quinidine—CYP1A1—epithelium—urinary bladder cancer	0.000663	0.00797	CbGeAlD
Quinidine—CYP1A2—renal system—urinary bladder cancer	0.000624	0.0075	CbGeAlD
Quinidine—CYP1A1—renal system—urinary bladder cancer	0.000615	0.00739	CbGeAlD
Quinidine—CYP1A1—urethra—urinary bladder cancer	0.000604	0.00726	CbGeAlD
Quinidine—CYP2B6—renal system—urinary bladder cancer	0.000598	0.00719	CbGeAlD
Quinidine—KCNH2—female reproductive system—urinary bladder cancer	0.000584	0.00701	CbGeAlD
Quinidine—CYP2E1—renal system—urinary bladder cancer	0.000561	0.00674	CbGeAlD
Quinidine—SCN3A—lymph node—urinary bladder cancer	0.000557	0.00669	CbGeAlD
Quinidine—SLC22A5—female reproductive system—urinary bladder cancer	0.000551	0.00663	CbGeAlD
Quinidine—CYP2E1—urethra—urinary bladder cancer	0.000551	0.00662	CbGeAlD
Quinidine—CYP2C8—female reproductive system—urinary bladder cancer	0.000534	0.00642	CbGeAlD
Quinidine—KCNH2—vagina—urinary bladder cancer	0.000528	0.00634	CbGeAlD
Quinidine—ORM1—lymph node—urinary bladder cancer	0.000507	0.00609	CbGeAlD
Quinidine—SLC22A5—vagina—urinary bladder cancer	0.000499	0.00599	CbGeAlD
Quinidine—CYP1A1—female reproductive system—urinary bladder cancer	0.000493	0.00592	CbGeAlD
Quinidine—SLC22A4—lymph node—urinary bladder cancer	0.000488	0.00586	CbGeAlD
Quinidine—CYP2C8—vagina—urinary bladder cancer	0.000483	0.0058	CbGeAlD
Quinidine—CYP2B6—female reproductive system—urinary bladder cancer	0.000479	0.00575	CbGeAlD
Quinidine—CYP2C9—female reproductive system—urinary bladder cancer	0.000474	0.0057	CbGeAlD
Quinidine—ABCB1—prostate gland—urinary bladder cancer	0.000469	0.00563	CbGeAlD
Quinidine—CYP3A4—renal system—urinary bladder cancer	0.000452	0.00543	CbGeAlD
Quinidine—CYP2E1—female reproductive system—urinary bladder cancer	0.000449	0.0054	CbGeAlD
Quinidine—CYP1A1—vagina—urinary bladder cancer	0.000446	0.00536	CbGeAlD
Quinidine—CYP2D6—renal system—urinary bladder cancer	0.000444	0.00534	CbGeAlD
Quinidine—CYP2B6—vagina—urinary bladder cancer	0.000433	0.0052	CbGeAlD
Quinidine—ABCC2—lymph node—urinary bladder cancer	0.000416	0.005	CbGeAlD
Quinidine—ABCB1—seminal vesicle—urinary bladder cancer	0.000397	0.00477	CbGeAlD
Quinidine—CYP3A4—female reproductive system—urinary bladder cancer	0.000362	0.00435	CbGeAlD
Quinidine—CYP2D6—female reproductive system—urinary bladder cancer	0.000356	0.00428	CbGeAlD
Quinidine—ABCB1—epithelium—urinary bladder cancer	0.000345	0.00414	CbGeAlD
Quinidine—KCNH2—lymph node—urinary bladder cancer	0.000341	0.0041	CbGeAlD
Quinidine—SLC22A5—lymph node—urinary bladder cancer	0.000323	0.00388	CbGeAlD
Quinidine—ABCB1—renal system—urinary bladder cancer	0.00032	0.00384	CbGeAlD
Quinidine—ABCB1—urethra—urinary bladder cancer	0.000314	0.00377	CbGeAlD
Quinidine—CYP1A1—lymph node—urinary bladder cancer	0.000288	0.00346	CbGeAlD
Quinidine—ABCB1—female reproductive system—urinary bladder cancer	0.000256	0.00308	CbGeAlD
Quinidine—ABCB1—vagina—urinary bladder cancer	0.000232	0.00278	CbGeAlD
Quinidine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000185	0.000948	CcSEcCtD
Quinidine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000184	0.000941	CcSEcCtD
Quinidine—Anorexia—Etoposide—urinary bladder cancer	0.000184	0.000941	CcSEcCtD
Quinidine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000184	0.00094	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000183	0.000938	CcSEcCtD
Quinidine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000183	0.000936	CcSEcCtD
Quinidine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000183	0.000936	CcSEcCtD
Quinidine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000182	0.00093	CcSEcCtD
Quinidine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000181	0.000924	CcSEcCtD
Quinidine—Hypotension—Etoposide—urinary bladder cancer	0.00018	0.000922	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00018	0.000919	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00018	0.000919	CcSEcCtD
Quinidine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000179	0.000914	CcSEcCtD
Quinidine—Renal failure—Methotrexate—urinary bladder cancer	0.000178	0.000911	CcSEcCtD
Quinidine—Neutropenia—Epirubicin—urinary bladder cancer	0.000178	0.00091	CcSEcCtD
Quinidine—Dizziness—Thiotepa—urinary bladder cancer	0.000178	0.000909	CcSEcCtD
Quinidine—Urticaria—Fluorouracil—urinary bladder cancer	0.000177	0.000903	CcSEcCtD
Quinidine—Asthma—Doxorubicin—urinary bladder cancer	0.000176	0.0009	CcSEcCtD
Quinidine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000176	0.000898	CcSEcCtD
Quinidine—Sweating—Methotrexate—urinary bladder cancer	0.000174	0.000889	CcSEcCtD
Quinidine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000174	0.000888	CcSEcCtD
Quinidine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000174	0.000888	CcSEcCtD
Quinidine—Dyspnoea—Etoposide—urinary bladder cancer	0.000172	0.00088	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000171	0.000877	CcSEcCtD
Quinidine—Vomiting—Thiotepa—urinary bladder cancer	0.000171	0.000874	CcSEcCtD
Quinidine—Rash—Thiotepa—urinary bladder cancer	0.000169	0.000866	CcSEcCtD
Quinidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000169	0.000865	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000169	0.000865	CcSEcCtD
Quinidine—Headache—Thiotepa—urinary bladder cancer	0.000168	0.000861	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000168	0.00086	CcSEcCtD
Quinidine—Decreased appetite—Etoposide—urinary bladder cancer	0.000168	0.000858	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000167	0.000855	CcSEcCtD
Quinidine—Renal failure—Epirubicin—urinary bladder cancer	0.000167	0.000853	CcSEcCtD
Quinidine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000167	0.000852	CcSEcCtD
Quinidine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000167	0.000852	CcSEcCtD
Quinidine—Jaundice—Epirubicin—urinary bladder cancer	0.000165	0.000845	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000165	0.000842	CcSEcCtD
Quinidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000164	0.000837	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—urinary bladder cancer	0.000164	0.000836	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000163	0.000832	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—urinary bladder cancer	0.000163	0.000832	CcSEcCtD
Quinidine—Sweating—Epirubicin—urinary bladder cancer	0.000163	0.000832	CcSEcCtD
Quinidine—Asthenia—Gemcitabine—urinary bladder cancer	0.000162	0.000829	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000161	0.000822	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000161	0.000822	CcSEcCtD
Quinidine—Pruritus—Gemcitabine—urinary bladder cancer	0.00016	0.000818	CcSEcCtD
Quinidine—Nausea—Thiotepa—urinary bladder cancer	0.00016	0.000816	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000159	0.000816	CcSEcCtD
Quinidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000159	0.000813	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000158	0.000809	CcSEcCtD
Quinidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000158	0.000807	CcSEcCtD
Quinidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000157	0.000804	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—urinary bladder cancer	0.000157	0.000802	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000156	0.000796	CcSEcCtD
Quinidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000155	0.000794	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—urinary bladder cancer	0.000155	0.000793	CcSEcCtD
Quinidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000155	0.000791	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—urinary bladder cancer	0.000154	0.000789	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000154	0.000787	CcSEcCtD
Quinidine—Urticaria—Etoposide—urinary bladder cancer	0.000153	0.000784	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000153	0.000783	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—urinary bladder cancer	0.000153	0.000782	CcSEcCtD
Quinidine—Body temperature increased—Etoposide—urinary bladder cancer	0.000153	0.00078	CcSEcCtD
Quinidine—Abdominal pain—Etoposide—urinary bladder cancer	0.000153	0.00078	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000152	0.000779	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000152	0.000779	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—urinary bladder cancer	0.000152	0.000778	CcSEcCtD
Quinidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000152	0.000777	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—urinary bladder cancer	0.000152	0.000776	CcSEcCtD
Quinidine—Asthenia—Cisplatin—urinary bladder cancer	0.000151	0.000773	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000151	0.000772	CcSEcCtD
Quinidine—Sweating—Doxorubicin—urinary bladder cancer	0.00015	0.000769	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00015	0.000769	CcSEcCtD
Quinidine—ABCB1—lymph node—urinary bladder cancer	0.00015	0.0018	CbGeAlD
Quinidine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000149	0.000763	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000147	0.000752	CcSEcCtD
Quinidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000147	0.000751	CcSEcCtD
Quinidine—Visual impairment—Epirubicin—urinary bladder cancer	0.000147	0.00075	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000147	0.00075	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000146	0.000749	CcSEcCtD
Quinidine—Chills—Methotrexate—urinary bladder cancer	0.000146	0.000747	CcSEcCtD
Quinidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000144	0.000737	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000144	0.000736	CcSEcCtD
Quinidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000144	0.000735	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000143	0.000733	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—urinary bladder cancer	0.000143	0.000729	CcSEcCtD
Quinidine—Rash—Gemcitabine—urinary bladder cancer	0.000142	0.000729	CcSEcCtD
Quinidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000142	0.000728	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—urinary bladder cancer	0.000142	0.000728	CcSEcCtD
Quinidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000142	0.000727	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—urinary bladder cancer	0.000142	0.000726	CcSEcCtD
Quinidine—Erythema—Methotrexate—urinary bladder cancer	0.000142	0.000724	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—urinary bladder cancer	0.000142	0.000724	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000142	0.000724	CcSEcCtD
Quinidine—Headache—Gemcitabine—urinary bladder cancer	0.000142	0.000724	CcSEcCtD
Quinidine—Flushing—Epirubicin—urinary bladder cancer	0.000141	0.000723	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000141	0.000723	CcSEcCtD
Quinidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000141	0.000722	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000141	0.00072	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000141	0.00072	CcSEcCtD
Quinidine—Rash—Fluorouracil—urinary bladder cancer	0.00014	0.000716	CcSEcCtD
Quinidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00014	0.000716	CcSEcCtD
Quinidine—Headache—Fluorouracil—urinary bladder cancer	0.000139	0.000712	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000139	0.000712	CcSEcCtD
Quinidine—Asthenia—Etoposide—urinary bladder cancer	0.000138	0.000708	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000138	0.000706	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000138	0.000703	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000137	0.000702	CcSEcCtD
Quinidine—Chills—Epirubicin—urinary bladder cancer	0.000137	0.000699	CcSEcCtD
Quinidine—Pruritus—Etoposide—urinary bladder cancer	0.000137	0.000698	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000136	0.000694	CcSEcCtD
Quinidine—Nausea—Gemcitabine—urinary bladder cancer	0.000134	0.000686	CcSEcCtD
Quinidine—Vomiting—Cisplatin—urinary bladder cancer	0.000134	0.000685	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—urinary bladder cancer	0.000133	0.000683	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—urinary bladder cancer	0.000133	0.000682	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000133	0.000681	CcSEcCtD
Quinidine—Rash—Cisplatin—urinary bladder cancer	0.000133	0.000679	CcSEcCtD
Quinidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000133	0.000679	CcSEcCtD
Quinidine—Erythema—Epirubicin—urinary bladder cancer	0.000133	0.000678	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—urinary bladder cancer	0.000133	0.000678	CcSEcCtD
Quinidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000132	0.000675	CcSEcCtD
Quinidine—Nausea—Fluorouracil—urinary bladder cancer	0.000132	0.000675	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000132	0.000673	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000131	0.000672	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000131	0.000669	CcSEcCtD
Quinidine—Flushing—Doxorubicin—urinary bladder cancer	0.000131	0.000669	CcSEcCtD
Quinidine—Dizziness—Etoposide—urinary bladder cancer	0.000128	0.000653	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000651	CcSEcCtD
Quinidine—Vertigo—Methotrexate—urinary bladder cancer	0.000127	0.000651	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000649	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—urinary bladder cancer	0.000127	0.000648	CcSEcCtD
Quinidine—Chills—Doxorubicin—urinary bladder cancer	0.000126	0.000646	CcSEcCtD
Quinidine—Nausea—Cisplatin—urinary bladder cancer	0.000125	0.00064	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—urinary bladder cancer	0.000125	0.000639	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000123	0.000631	CcSEcCtD
Quinidine—Convulsion—Methotrexate—urinary bladder cancer	0.000123	0.000628	CcSEcCtD
Quinidine—Vomiting—Etoposide—urinary bladder cancer	0.000123	0.000627	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000123	0.000627	CcSEcCtD
Quinidine—Erythema—Doxorubicin—urinary bladder cancer	0.000123	0.000627	CcSEcCtD
Quinidine—Agitation—Epirubicin—urinary bladder cancer	0.000122	0.000623	CcSEcCtD
Quinidine—Rash—Etoposide—urinary bladder cancer	0.000122	0.000622	CcSEcCtD
Quinidine—Dermatitis—Etoposide—urinary bladder cancer	0.000122	0.000622	CcSEcCtD
Quinidine—Headache—Etoposide—urinary bladder cancer	0.000121	0.000618	CcSEcCtD
Quinidine—Myalgia—Methotrexate—urinary bladder cancer	0.000121	0.000617	CcSEcCtD
Quinidine—Chest pain—Methotrexate—urinary bladder cancer	0.000121	0.000617	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00012	0.000612	CcSEcCtD
Quinidine—Vertigo—Epirubicin—urinary bladder cancer	0.000119	0.000609	CcSEcCtD
Quinidine—Syncope—Epirubicin—urinary bladder cancer	0.000119	0.000608	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—urinary bladder cancer	0.000119	0.000607	CcSEcCtD
Quinidine—Palpitations—Epirubicin—urinary bladder cancer	0.000117	0.000599	CcSEcCtD
Quinidine—Confusional state—Methotrexate—urinary bladder cancer	0.000117	0.000596	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000116	0.000596	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000116	0.000591	CcSEcCtD
Quinidine—Convulsion—Epirubicin—urinary bladder cancer	0.000115	0.000587	CcSEcCtD
Quinidine—Nausea—Etoposide—urinary bladder cancer	0.000115	0.000586	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000113	0.00058	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000113	0.000579	CcSEcCtD
Quinidine—Myalgia—Epirubicin—urinary bladder cancer	0.000113	0.000577	CcSEcCtD
Quinidine—Chest pain—Epirubicin—urinary bladder cancer	0.000113	0.000577	CcSEcCtD
Quinidine—Agitation—Doxorubicin—urinary bladder cancer	0.000113	0.000576	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—urinary bladder cancer	0.000112	0.000574	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000112	0.000573	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000112	0.000571	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—urinary bladder cancer	0.00011	0.000563	CcSEcCtD
Quinidine—Anorexia—Methotrexate—urinary bladder cancer	0.00011	0.000563	CcSEcCtD
Quinidine—Syncope—Doxorubicin—urinary bladder cancer	0.00011	0.000562	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00011	0.000561	CcSEcCtD
Quinidine—Confusional state—Epirubicin—urinary bladder cancer	0.000109	0.000558	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—urinary bladder cancer	0.000108	0.000554	CcSEcCtD
Quinidine—Oedema—Epirubicin—urinary bladder cancer	0.000108	0.000553	CcSEcCtD
Quinidine—Hypotension—Methotrexate—urinary bladder cancer	0.000108	0.000552	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000108	0.000551	CcSEcCtD
Quinidine—Shock—Epirubicin—urinary bladder cancer	0.000106	0.000544	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—urinary bladder cancer	0.000106	0.000543	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000106	0.000543	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000106	0.000542	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—urinary bladder cancer	0.000106	0.00054	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000105	0.000539	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—urinary bladder cancer	0.000105	0.000537	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000105	0.000535	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—urinary bladder cancer	0.000104	0.000534	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—urinary bladder cancer	0.000104	0.000534	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000104	0.00053	CcSEcCtD
Quinidine—Anorexia—Epirubicin—urinary bladder cancer	0.000103	0.000527	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000103	0.000527	CcSEcCtD
Quinidine—Hypotension—Epirubicin—urinary bladder cancer	0.000101	0.000517	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000101	0.000516	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—urinary bladder cancer	0.0001	0.000514	CcSEcCtD
Quinidine—Oedema—Doxorubicin—urinary bladder cancer	0.0001	0.000512	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.98e-05	0.00051	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.85e-05	0.000504	CcSEcCtD
Quinidine—Shock—Doxorubicin—urinary bladder cancer	9.85e-05	0.000504	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.81e-05	0.000502	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.8e-05	0.000501	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—urinary bladder cancer	9.77e-05	0.0005	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—urinary bladder cancer	9.72e-05	0.000497	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	9.68e-05	0.000495	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—urinary bladder cancer	9.64e-05	0.000493	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—urinary bladder cancer	9.54e-05	0.000488	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—urinary bladder cancer	9.52e-05	0.000487	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	9.45e-05	0.000483	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—urinary bladder cancer	9.4e-05	0.000481	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—urinary bladder cancer	9.35e-05	0.000478	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.34e-05	0.000478	CcSEcCtD
Quinidine—Urticaria—Methotrexate—urinary bladder cancer	9.18e-05	0.00047	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—urinary bladder cancer	9.14e-05	0.000467	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—urinary bladder cancer	9.14e-05	0.000467	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	9.12e-05	0.000466	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—urinary bladder cancer	8.92e-05	0.000456	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—urinary bladder cancer	8.91e-05	0.000456	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.84e-05	0.000452	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—urinary bladder cancer	8.7e-05	0.000445	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.64e-05	0.000442	CcSEcCtD
Quinidine—Urticaria—Epirubicin—urinary bladder cancer	8.59e-05	0.000439	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—urinary bladder cancer	8.55e-05	0.000437	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—urinary bladder cancer	8.55e-05	0.000437	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—urinary bladder cancer	8.52e-05	0.000436	CcSEcCtD
Quinidine—Asthenia—Methotrexate—urinary bladder cancer	8.29e-05	0.000424	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.25e-05	0.000422	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	8.18e-05	0.000419	CcSEcCtD
Quinidine—Pruritus—Methotrexate—urinary bladder cancer	8.18e-05	0.000418	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—urinary bladder cancer	7.97e-05	0.000408	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—urinary bladder cancer	7.95e-05	0.000407	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—urinary bladder cancer	7.91e-05	0.000405	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—urinary bladder cancer	7.91e-05	0.000405	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—urinary bladder cancer	7.91e-05	0.000404	CcSEcCtD
Quinidine—Asthenia—Epirubicin—urinary bladder cancer	7.76e-05	0.000397	CcSEcCtD
Quinidine—Pruritus—Epirubicin—urinary bladder cancer	7.65e-05	0.000391	CcSEcCtD
Quinidine—Dizziness—Methotrexate—urinary bladder cancer	7.64e-05	0.000391	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—urinary bladder cancer	7.4e-05	0.000379	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.37e-05	0.000377	CcSEcCtD
Quinidine—Vomiting—Methotrexate—urinary bladder cancer	7.35e-05	0.000376	CcSEcCtD
Quinidine—Rash—Methotrexate—urinary bladder cancer	7.29e-05	0.000373	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—urinary bladder cancer	7.28e-05	0.000372	CcSEcCtD
Quinidine—Headache—Methotrexate—urinary bladder cancer	7.24e-05	0.00037	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—urinary bladder cancer	7.18e-05	0.000367	CcSEcCtD
Quinidine—Dizziness—Epirubicin—urinary bladder cancer	7.15e-05	0.000366	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—urinary bladder cancer	7.08e-05	0.000362	CcSEcCtD
Quinidine—Vomiting—Epirubicin—urinary bladder cancer	6.88e-05	0.000352	CcSEcCtD
Quinidine—Nausea—Methotrexate—urinary bladder cancer	6.87e-05	0.000351	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—urinary bladder cancer	6.85e-05	0.00035	CcSEcCtD
Quinidine—Rash—Epirubicin—urinary bladder cancer	6.82e-05	0.000349	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—urinary bladder cancer	6.81e-05	0.000348	CcSEcCtD
Quinidine—Headache—Epirubicin—urinary bladder cancer	6.78e-05	0.000347	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—urinary bladder cancer	6.62e-05	0.000338	CcSEcCtD
Quinidine—Nausea—Epirubicin—urinary bladder cancer	6.42e-05	0.000329	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—urinary bladder cancer	6.36e-05	0.000325	CcSEcCtD
Quinidine—Rash—Doxorubicin—urinary bladder cancer	6.31e-05	0.000323	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—urinary bladder cancer	6.3e-05	0.000322	CcSEcCtD
Quinidine—Headache—Doxorubicin—urinary bladder cancer	6.27e-05	0.000321	CcSEcCtD
Quinidine—Nausea—Doxorubicin—urinary bladder cancer	5.94e-05	0.000304	CcSEcCtD
Quinidine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.27e-05	0.000122	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.27e-05	0.000122	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	0.000121	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.26e-05	0.000121	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.26e-05	0.000121	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.26e-05	0.00012	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	1.26e-05	0.00012	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.25e-05	0.00012	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.24e-05	0.000119	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.24e-05	0.000119	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	1.24e-05	0.000119	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	1.24e-05	0.000119	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.22e-05	0.000117	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	0.000117	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.22e-05	0.000116	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—JAG1—urinary bladder cancer	1.21e-05	0.000116	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.21e-05	0.000116	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.2e-05	0.000115	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.2e-05	0.000115	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.2e-05	0.000115	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000115	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.19e-05	0.000114	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	1.19e-05	0.000114	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.18e-05	0.000114	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.17e-05	0.000113	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.17e-05	0.000112	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.17e-05	0.000112	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.17e-05	0.000112	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	1.17e-05	0.000112	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.16e-05	0.000111	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.16e-05	0.000111	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.16e-05	0.000111	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.13e-05	0.000109	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.12e-05	0.000107	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.11e-05	0.000106	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.11e-05	0.000106	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.11e-05	0.000106	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.1e-05	0.000105	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.1e-05	0.000105	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.1e-05	0.000105	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	1.1e-05	0.000105	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.1e-05	0.000105	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.09e-05	0.000104	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.09e-05	0.000104	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.07e-05	0.000103	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTGS2—urinary bladder cancer	1.07e-05	0.000102	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.06e-05	0.000102	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.03e-05	9.91e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.03e-05	9.91e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—RHOA—urinary bladder cancer	1.03e-05	9.84e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.02e-05	9.82e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.02e-05	9.82e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	9.79e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.02e-05	9.76e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.02e-05	9.73e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1e-05	9.61e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1e-05	9.58e-05	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.96e-06	9.55e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	9.94e-06	9.53e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.85e-06	9.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—S100B—urinary bladder cancer	9.84e-06	9.43e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	9.8e-06	9.39e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.79e-06	9.38e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	9.7e-06	9.3e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	9.46e-06	9.06e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.37e-06	8.98e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	9.35e-06	8.96e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—RHOA—urinary bladder cancer	9.33e-06	8.94e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTEN—urinary bladder cancer	9.32e-06	8.93e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	9.32e-06	8.93e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	9.3e-06	8.91e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	9.24e-06	8.85e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	9.19e-06	8.81e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	9.19e-06	8.81e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	9.11e-06	8.73e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	9.02e-06	8.64e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	9e-06	8.62e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	9e-06	8.62e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.93e-06	8.56e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	8.93e-06	8.55e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	8.91e-06	8.53e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—EP300—urinary bladder cancer	8.89e-06	8.52e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	8.89e-06	8.52e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	8.85e-06	8.48e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NQO1—urinary bladder cancer	8.84e-06	8.47e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	8.8e-06	8.43e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	8.76e-06	8.39e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	8.76e-06	8.39e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.71e-06	8.34e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	8.64e-06	8.28e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	8.62e-06	8.26e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	8.62e-06	8.26e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.59e-06	8.23e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	8.59e-06	8.23e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	8.56e-06	8.2e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	8.54e-06	8.18e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	8.5e-06	8.14e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	8.49e-06	8.13e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	8.49e-06	8.13e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	8.47e-06	8.11e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	8.46e-06	8.11e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	8.46e-06	8.1e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.36e-06	8.01e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.33e-06	7.98e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	8.29e-06	7.94e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	8.26e-06	7.92e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.19e-06	7.85e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	8.19e-06	7.84e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	8.13e-06	7.79e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	8.12e-06	7.78e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.02e-06	7.68e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	7.98e-06	7.65e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	7.96e-06	7.63e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	7.96e-06	7.62e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	7.87e-06	7.54e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	7.82e-06	7.5e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	7.8e-06	7.47e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	7.78e-06	7.46e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	7.78e-06	7.45e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	7.78e-06	7.45e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	7.63e-06	7.31e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	7.5e-06	7.19e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	7.45e-06	7.14e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—EP300—urinary bladder cancer	7.42e-06	7.11e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	7.38e-06	7.07e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	7.32e-06	7.01e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.3e-06	6.99e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	7.15e-06	6.85e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	7.06e-06	6.76e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	7.01e-06	6.71e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	6.99e-06	6.7e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.99e-06	6.7e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	6.95e-06	6.66e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	6.95e-06	6.66e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.89e-06	6.6e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	6.88e-06	6.59e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TYMS—urinary bladder cancer	6.86e-06	6.57e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.85e-06	6.56e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	6.78e-06	6.49e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	6.78e-06	6.49e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	6.76e-06	6.48e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	6.76e-06	6.48e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.67e-06	6.39e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	6.66e-06	6.38e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	6.59e-06	6.31e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6.56e-06	6.28e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	6.52e-06	6.25e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GPX1—urinary bladder cancer	6.49e-06	6.22e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.46e-06	6.19e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	6.45e-06	6.18e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.41e-06	6.14e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.39e-06	6.12e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.39e-06	6.12e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	6.37e-06	6.11e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	6.35e-06	6.08e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.33e-06	6.07e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.33e-06	6.07e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	6.33e-06	6.06e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	6.2e-06	5.94e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.12e-06	5.86e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	6.11e-06	5.85e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	6.1e-06	5.84e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	6.09e-06	5.83e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	6.08e-06	5.83e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.06e-06	5.81e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	6.01e-06	5.76e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.01e-06	5.75e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	5.99e-06	5.74e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	5.98e-06	5.73e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.97e-06	5.72e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	5.95e-06	5.7e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	5.89e-06	5.64e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	5.84e-06	5.6e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—EP300—urinary bladder cancer	5.83e-06	5.58e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—EP300—urinary bladder cancer	5.82e-06	5.57e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.7e-06	5.46e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	5.69e-06	5.45e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	5.65e-06	5.42e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.65e-06	5.41e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.6e-06	5.36e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	5.58e-06	5.34e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	5.51e-06	5.28e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	5.47e-06	5.25e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.45e-06	5.22e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—EP300—urinary bladder cancer	5.42e-06	5.2e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	5.41e-06	5.18e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	5.41e-06	5.18e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	5.36e-06	5.13e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.18e-06	4.96e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	5.18e-06	4.96e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	5.1e-06	4.89e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.09e-06	4.87e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	5.07e-06	4.86e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—urinary bladder cancer	4.86e-06	4.65e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	4.84e-06	4.63e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	4.81e-06	4.6e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	4.78e-06	4.58e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	4.78e-06	4.58e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	4.67e-06	4.47e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	4.62e-06	4.43e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.58e-06	4.39e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.54e-06	4.35e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.54e-06	4.35e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	4.52e-06	4.33e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	4.51e-06	4.32e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	4.43e-06	4.24e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.4e-06	4.21e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.39e-06	4.2e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	4.37e-06	4.19e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.36e-06	4.18e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	4.36e-06	4.18e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	4.35e-06	4.17e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—EP300—urinary bladder cancer	4.31e-06	4.13e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.22e-06	4.05e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—EP300—urinary bladder cancer	4.22e-06	4.04e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.18e-06	4e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.18e-06	4e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	4.17e-06	4e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	4.15e-06	3.97e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	4.03e-06	3.86e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4e-06	3.83e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—EP300—urinary bladder cancer	3.98e-06	3.81e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.93e-06	3.76e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.88e-06	3.72e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.83e-06	3.67e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.82e-06	3.66e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	3.73e-06	3.57e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.69e-06	3.54e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—EP300—urinary bladder cancer	3.65e-06	3.5e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	3.61e-06	3.46e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.6e-06	3.45e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.57e-06	3.42e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	3.54e-06	3.39e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	3.34e-06	3.2e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.33e-06	3.19e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—EP300—urinary bladder cancer	3.18e-06	3.05e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.14e-06	3.01e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.11e-06	2.98e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.05e-06	2.92e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.99e-06	2.87e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.99e-06	2.87e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.97e-06	2.84e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	2.97e-06	2.84e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.88e-06	2.75e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	2.84e-06	2.72e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.66e-06	2.55e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.54e-06	2.43e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.35e-06	2.26e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.05e-06	1.97e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.96e-06	1.88e-05	CbGpPWpGaD
